Sign in

GWTI on OTC

GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES

GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES is an American industrial organic chemicals company, incorporated in Texas.1 It is headquartered in Arlington, Texas.1 Its shares trade on OTC under the symbol GWTI.1

$0.01 up 0.00 (0.00%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 21, 2026.

Overview

Compare with SUIC Worldwide Holdings Ltd., BLUE BIOFUELS, INC. or Quantum Genesis AI Corp., or pick any stock.

  • TickerGWTI on OTC1
  • IndustryIndustrial Organic Chemicals1
  • HeadquartersArlington, Texas1
  • Incorporated inTX3
  • Business address1521 North Cooper Street, Suite 205, Arlington, Tx 760113
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

GTL process fronted by our patented and revolutionary gas reformation unit, the G-Reformer®, makes us the innovator in GTL technology.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income5678910-$3.7M in 2025+52% since 2019
-$4.0M-$3.0M-$2.0M-$1.0M02019: -$2.4M-$2.4M20192020: -$1.4M-$1.4M2020−44%2021: -$1.1M-$1.1M2021−18%2022: -$942.9K-$942.9K2022−16%2023: -$960.7K-$960.7K2023+2%2024: -$894.3K-$894.3K2024−7%2025: -$3.7M-$3.7M2025+313%
Net income5678910-$2.0M in 2025−47% since 2019
-$4.0M-$3.0M-$2.0M-$1.0M02019: -$3.7M-$3.7M20192020: -$2.5M-$2.5M2020−31%2021: -$1.7M-$1.7M2021−31%2022: -$1.5M-$1.5M2022−13%2023: -$1.6M-$1.6M2023+4%2024: -$1.5M-$1.5M2024−4%2025: -$2.0M-$2.0M2025+29%

Every line of the income statement as filed: the last 2 fiscal years, latest first.10

Period ending2025-12-312024-12-31
General and administrative expenses$2.5M$844.3K
Research and development$1.2M$50.0K
Total operating expenses$3.7M$894.3K
Loss from operations-$3.7M-$894.3K
Forfeiture of non-refundable deposits$1.7M
Gain on legal settlement$648.8K
Interest expense-$613.1K-$619.3K
Total other income (expense) - net$1.7M-$619.3K
Net loss-$2.0M-$1.5M
Loss per share - basic$0.00$0.00
Loss per share - diluted$0.00$0.00
Weighted average number of shares - basic444.9M shares413.1M shares
Weighted average number of shares - diluted444.9M shares413.1M shares

Compare GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES with another company

What it owns

What GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Properties, in its own words

Our principal office is 1521 North Cooper St., Suite 205, Arlington, Texas 76011, leased at a rate of $981.00 per month. We believe these facilities are adequate for at least the next 12 months. We expect that we could relocate to other suitable facilities at comparable rates, should we need more or less space.

Item 2 of the 10-K filed Apr 15, 2026.4

Leadership

Who has led GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kevin Bentley2015

Chair

  1. Randy Moseley2015

President

  1. Richard Halden2015
  2. Ransom Bert Jones2017
  3. David Patrick Six2017
  4. John William Olynick2018

Chief financial officer

  1. Randy Moseley2015
  2. Ransom Bert Jones2017
20202025
Board members and other officers (11)

Former names

  • GREENWAY TECHNOLOGIES INCJul 18, 2017 to Aug 11, 20253
  • UMED HOLDINGS, INC.Aug 29, 2013 to Jun 29, 20173

Timeline

  1. Jun 15, 20268-K Executive or director change25
  2. Jun 3, 20268-K Executive or director change; Regulation FD disclosure26
  3. Apr 17, 20268-K Change of auditor27
  4. Feb 27, 20268-K Executive or director change28
  5. Nov 28, 20258-K Executive or director change29
  6. Nov 5, 20258-K Entered a material agreement; Unregistered sale of shares30
  7. Jul 15, 20258-K Executive or director change31
  8. Jun 23, 20258-K Other events32
  9. May 23, 20258-K Entered a material agreement; Bylaws or fiscal year changed; Other events33
  10. Dec 16, 20248-K Entered a material agreement34
  11. Oct 24, 20248-K Entered a material agreement35
  12. Aug 28, 20248-K Entered a material agreement36
  13. Mar 25, 2015New chief executive Kevin Bentley becomes CEO13

Filings

58 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 18 major events, 19 other. The latest 20:

  1. Sep 28, 202610-Q EDGAR
  2. Jun 15, 20268-K EDGAR
  3. Jun 3, 20268-K EDGAR
  4. May 20, 202610-Q EDGAR
  5. May 15, 2026NT 10-Q EDGAR
  6. Apr 17, 20268-K EDGAR
  7. Apr 15, 202610-K EDGAR
  8. Mar 27, 2026NT 10-K EDGAR
  9. Feb 27, 20268-K EDGAR
  10. Nov 28, 20258-K EDGAR
  11. Nov 13, 202510-Q EDGAR
  12. Nov 5, 20258-K EDGAR
  13. Aug 11, 202510-Q EDGAR
  14. Jul 15, 20258-K EDGAR
  15. Jun 23, 20258-K EDGAR
  16. May 23, 20258-K EDGAR
  17. May 9, 202510-Q EDGAR
  18. Mar 11, 202510-K EDGAR
  19. Dec 16, 20248-K EDGAR
  20. Nov 13, 202410-Q EDGAR

The 58 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARGREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES1
  • CIK0001572386
  • Employer ID (EIN)90-08935944
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated intexas4
  • Fiscal year endsDecember 311
  • Industry code (SIC)2860 Industrial Organic Chemicals1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address1521 North Cooper Street, Suite 205, Arlington, TX 760111
  • Phone(561) 809-46441
  • Shares outstanding464,871,204 as of Sep 28, 202612
  • Public float$27.8M as of Jun 30, 20254
  • AuditorStephano Slack LLC, Wayne, Pennsylvania PCAOB ID 35234
  • On EDGAR sinceAug 29, 20131
  • Filings225 in all: 8-K (45), 10-Q (39), NT 10-Q (19), UPLOAD (17), 10-K (13), NT 10-K (11), 4 (10), 3 (9)1
    All 28 form types

    DFRN14A (8), 10-K/A (7), 8-K/A (6), 10-Q/A (5), 5 (5), CORRESP (5), SC 13D (5), DFAN14A (4), 10-12G/A (2), 3/A (2), D (2), DEF 14A (2), PRE 14A (2), 10-12G (1), D/A (1), DEFA14A (1), DEFC14A (1), PREC14A (1), SC 13D/A (1), SC 13G (1)

  • Latest filingsAnnual report (10-K) Apr 15, 2026
    Quarterly report (10-Q) Sep 28, 2026
    Proxy statement (DEF 14A) Nov 18, 2019
    Latest 8-K (8-K) Jun 15, 2026

Securities registered for trading

ClassSymbolExchange
Common stock, par value $0.001 per shareGWTI

From the cover page of the 10-K filed Apr 15, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES names in Item 1A of its 10-K filed Apr 15, 2026: 25 risks under these headings, as written.4

  • Risks Related to our Business and Operations
  • We may not be able to raise the additional capital necessary to execute our business strategy, which includes the production, sale and/or licensing of our proprietary GTL technology solutions to oil and gas operators in the United States and elsewhere.
  • Our limited operating history may not serve as an adequate basis to judge our future prospects and results of operations.
  • We have historically incurred losses.
  • Establishing revenues and achieving profitability will depend on our ability to fully develop, certify and commercialize our GTL Technology, including successfully marketing our GTL Technology to customers and complying with possible regulations.
  • We may encounter substantial competition in our industry and a failure to compete effectively may adversely affect our ability to generate revenue.
  • Although the longevity of patents in the United States are limited in duration to 20 years, this should not affect the Company’s long-term ability to successfully monetize the intellectual property it owns.
  • We are currently dependent on one equipment fabricator, the loss of which could adversely impact our operations.
  • We are dependent on a limited number of key executives, consultants, the loss of any of which could negatively impact our business.
  • If our research and development agreements with UTA are terminated, we may lose access to certain of the scientists that were instrumental in developing our technology.
  • Our quarterly results may fluctuate substantially and if we fail to meet the expectations of our investors or analysts, our stock price could decline substantially.
  • We may have difficulty in attracting and retaining outside independent directors to our Board of Directors as a result of their concerns relating to potentially increased personal exposure to lawsuits and shareholder claims by virtue of holding those positions.
The other 14 risks
  • Our future success relies upon our proprietary GTL Technology. We may not have the resources to enforce our proprietary rights through litigation or otherwise. The loss of exclusive right to our GTL Technology could have a material adverse effect on our business, financial condition and results of operations.
  • Our ability to obtain field-related operating hazards insurance may be constrained by our limited operational history.
  • Our GTL Technology is subject to the changing of applicable U.S. laws and regulations.
  • Acts of terrorism, responses to acts of terrorism and acts of war may impact our business and our ability to raise capital.
  • We may fail to establish and maintain strategic relationships.
  • Risks Relating to Our Common Stock
  • We may need to raise additional capital. If we are unable to raise additional capital, our business may fail, or our operating results and our share price may be materially adversely affected.
  • Issuance of additional Common Stock in exchange for services or to repay debt would dilute Shareholders’ proportionate ownership and voting rights and could have a negative impact on the market price of our Common Stock.
  • Even though our shares of Common Stock are publicly traded, an investor’s shares may not be “free-trading” and investors may be unable to sell their shares of Common Stock at or above their purchase price, which may result in substantial losses to the investor.
  • Due to the fact that the Company did not timely file its Form 10-K for the fiscal year ended December 31, 2023 and its Form 10-Q for the quarterly period ended March 31, 2024, it was removed from the OTCQB marketplace, operated by the OTC Markets Group, Inc. (the “OTCMG” and placed on OTCMG “Pink Market,”which limits the ability of broker-dealers to sell our securities and the ability of Shareholders to easily sell their securities in the secondary market. All of the Company’s filings with the SEC are now current and the stock is now trading on its historical marketplace, the OTCQB.
  • Volatility in the share price for our Common Stock may subject us to securities litigation.
  • We do not intend to pay dividends on shares of our Common Stock.
  • Our substantial level of indebtedness could adversely affect our financial condition.
  • The market for penny stocks has suffered in recent years from patterns of fraud and abuse.
  • Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on our business and stock price.

Legal proceedings

On September 7, 2021, the Company was served with a demand for mediation and potential arbitration by Gregory Sanders (“Plaintiff”), a previous employee of the Company. The demand claims Mr. Sanders had an employment agreement with the Company entitling him to certain compensation payments under the contract. No conclusion was met during mediation which occurred in the fourth quarter of 2021. On October 25, 2023, there was a hearing on Plaintiff’s motion for summary judgement. Plaintiff asserted 3 motions, all of which were denied by the court, as ordered on November 1, 2023. Plaintiff withdrew his action against the Company on January 11, 2024 and the court so ordered on the same date.

On November 8, 2023, the Company was served with a demand for payments under various agreements with the plaintiffs. The Plaintiffs are Ric Halden, Randy Moseley, Tunstall Canyon Group, LLC (“Tunstall Canyon”) and Chisos Equity Consultants, LLC (“Chisos”). Ric Halden and Randy Moseley were founders of the Company and served as officers and directors of the Company until 2017, when each of them resigned all positions with the Company. The Company believes that Tunstall Canyon and Chisos are majority-owned by Ric Halden. As of June 30, 2025, the Company had accrued liabilities in the amount of $1,672,074 to Ric Halden, Randy Moseley and Tunstall Canyon, which are all included in the liabilities reflected on the accompanying consolidated balance sheet. The court set an original trial date for November 25, 2024. The Plaintiffs and the Company petitioned the Court for a new trial date, which was granted and a new trial date was set for May 26, 2025. On March 28, 2025, Plaintiffs and the Company again petitioned the Court for a new trial date. The request was granted and the trial was reset set for September 15, 2025. Trial was subsequently reset to December 1, 2025.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
    Yahoo FinanceGWTI quote
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
    SEC EDGAROther events
  33. 33
  34. 34
  35. 35
  36. 36